Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care-Reference-Cited by-同舟云学术

Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care

Published:2017-08 Issue: Volume:263 Page:36-41
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Guglielmi Valeria,Bellia Alfonso,Pecchioli Serena,Della-Morte David,Parretti Damiano,Cricelli Iacopo,Medea Gerardo,Sbraccia Paolo,Lauro Davide,Cricelli Claudio,Lapi Francesco

Funder

Amgen

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

2. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project;Conroy;Eur. Heart J.,2003

3. Editor’s presentation

4. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1-executive summary;Jacobson;J. Clin. Lipidol.,2014

5. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult;Anderson;Can. J. Cardiol.,2013

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCSK9 Inhibitor with Statin Therapy for Intracranial Artery Stenosis ( PISTIAS): Rationale and design of a multicenter randomized controlled trial;International Journal of Stroke;2024-08-15

2. Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy;Advances in Therapy;2024-07-04

3. Gender differences and hypercholesterolemia: real-world evidence from the study WECARE (Women Effective CArdiovascular Risk Evaluation);Global and Regional Health Technology Assessment;2024-06-11

4. Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease;Reviews in Cardiovascular Medicine;2024-05-23

5. 25 years of lipid-lowering therapy: secular trends in therapy of coronary patients;Wiener klinische Wochenschrift;2024-05-14